Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01483976 · ClinicalTrials.gov registry record · Phase 3
Comparison of Medical Nutritional Supplements
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 27
- Enrollment target
NCT01483976: Completed Phase 3 study, sponsored by Abbott Nutrition.
NCT01483976 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 27 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01483976, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 27 participants
- Enrollment target
Study Summary
The objective of this study is to verify changes in protein metabolism after ingesting a oral medical nutritional supplement.
Primary Outcome
Via amino acid tracers
Interventions
- OTHER Oral medical nutritional supplement
- OTHER Experimental oral medical nutritional supplement with AN777
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-05 |
| Phase | Phase 3 |
What the finished NCT01483976 record still lists
NCT01483976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Oral medical nutritional supplement is the first listed.
NCT01483976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01483976 about?
NCT01483976 is a clinical study titled "Comparison of Medical Nutritional Supplements". The objective of this study is to verify changes in protein metabolism after ingesting a oral medical nutritional supplement.
What is the current status of trial NCT01483976?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 27 participants. The study started on 2011-10. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01483976?
The interventions under investigation include: Oral medical nutritional supplement (OTHER), Experimental oral medical nutritional supplement with AN777 (OTHER).
Who is sponsoring clinical trial NCT01483976?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01483976's enrollment target sits among peer trials
27 1936th of 2000 higher than 64 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia